Skip to main content
. 2020 May 26;146(1):137–146.e3. doi: 10.1016/j.jaci.2020.05.019

Table I.

Demographic and clinical characteristic of the patients at baseline

Characteristic Total Control group
Ruxolitinib group
P value
(N = 21) (N = 20)
Age (y) 63 (58-68) 64 (59-71) 63 (51-65) .123
Sex >.999
 Female 17 (41.5) 9 (42.9) 8 (40.0)
 Male 24 (58.5) 12 (57.1) 12 (60.0)
Comorbidity 27 (65.9) 13 (61.9) 14 (70.0) .744
 Hypertension 16 (39.0) 9 (42.9) 7 (35.0) .751
 Diabetes 8 (19.5) 3 (14.3) 5 (25.0) .454
 Coronary artery heart disease 3 (7.3) 1 (4.8) 2 (10.0) .606
Smoking history 4 (9.8) 2 (9.5) 2 (10.0) >.999
Respiratory rate >24 breaths/min 8 (19.5) 4 (19.0) 4 (20.0) >.999
Pulse ≥125 beats/min 7 (17.1) 3 (14.3) 4 (20.0) .697
Fever (temperature ≥37.3°C) 5 (12.2) 2 (9.5) 3 (15.0) .663
White-cell count (×109/L) 8.4 (6.1-11.0) 8.3 (6.7-11.0) 8.4 (5.6-11.0) .652
 <4 2 (4.9) 0 (0.0) 2 (10.0) .512
 4-10 26 (63.4) 14 (66.7) 12 (60.0)
 >10 13 (31.7) 7 (33.3) 6 (30.0)
Lymphocyte count (×109/L) 1.1 (0.92-1.6) 1.2 (0.97-2.0) 1.0 (0.76-1.2) .084
 ≥1.0 25 (61.0) 15 (71.4) 10 (50.0) .208
 <1.0 16 (39.0) 6 (28.6) 10 (50.0)
Platelet count 264 (173-314) 214 (175-285) 297 (165-355) .114
 ≥100 36 (87.8) 19 (90.5) 17 (85.0) .663
 <100 5 (12.2) 2 (9.5) 3 (15.0)
Serum creatinine (μmol/L) 67 (56-75) 66 (60-74) 69 (52-75) .872
 ≤133 38 (92.7) 20 (95.2) 18 (90.0) .606
 >133 3 (7.3) 1 (4.8) 2 (10.0)
Aspartate aminotransferase (U/L) 36 (23-68) 35 (19-88) 39 (26-52) .742
 ≤40 24 (58.5) 13 (61.9) 11 (55.0) .758
 >40 17 (41.5) 8 (38.1) 9 (45.0)
Alanine aminotransferase (U/L) 25 (17-46) 23 (18-50) 26 (17-47) .841
 ≤50 30 (73.2) 15 (71.4) 15 (75.0) >.999
 >50 11 (26.8) 6 (28.6) 5 (25.0)
Lactate dehydrogenase (U/L) 275 (225-413) 300 (226-438) 262 (213-384) .489
 ≤245 16 (39.0) 8 (38.1) 8 (40.0) >.999
 >245 25 (61.0) 13 (61.9) 12 (60.0)
Albumin (g/L) 32.0 (30.0-34.0) 32.0 (30.0-34.0) 32.0 (30.0-35.0) .821
 ≤35 32 (78.0) 17 (81.0) 15 (75.0) .719
 >35 9 (22.0) 4 (19.0) 5 (25.0)
D-Dimer (μg/mL) 2.4 (0.65-7.5) 2.5 (0.68-15.0) 2.1 (0.62-3.5) .248
 ≤1.0 14 (34.1) 6 (28.6) 8 (40.0) >.999
 >1.0 23 (56.1) 13 (61.9) 10 (50.0)
 Missing data 4 (9.8) 2 (9.5) 2 (10.0)
High-sensitive cardiac troponin I (ng/mL) 3.5 (2.0-6.3) 3.0 (1.6-6.8) 4.1 (2.2-6.5) .483
 ≤28.0 33 (80.5) 18 (85.7) 15 (75.0) .653
 >28.0 5 (12.2) 2 (9.5) 3 (15.0)
 Missing data 3 (7.3) 1 (4.8) 2 (10.0)

Data are median (IQR) or n (%).